HealthQuill Drugs
A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal data" might have been compromised.
Drugs Medical Pharma

Ransomware group behind cyberattack: Sun Pharma

A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal.

Read More
The US FDA plans to permit the use of salt substitutes in daily food, such as bread, cheeses and ketchup, to reduce the harmful effects of sodium intake that leads to heart attacks and strokes.
Drugs Health Pharma

FDA to permit salt substitutes to fight heart disease in US

The US FDA plans to permit the use of salt substitutes in daily food, such as bread, cheeses and ketchup, to reduce the.

Read More
Smokers may benefit from Sanofi's asthma drug after a phase III trial showed "significant improvements in lung function, quality of life" and uncontrolled chronic obstructive pulmonary disease respiratory symptoms.
Drugs Health Pharma

Sanofi-Regeneron’s trial drug may let smokers breathe easy

Smokers may benefit from Sanofi's asthma drug after a phase III trial showed "significant improvements in lung function, quality of life" and uncontrolled.

Read More
cancer
Drugs Health Medical Pharma

Experimental pill effective in treating third of leukemia patients in phase I trial

The pill, revumenib, has shown benefit in treating both adults and children with certain type of acute leukemia.

Read More
BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.
Drugs Medical Pharma

BioNTech, OncoC4 in pact to develop drug for solid tumours

BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.

Read More
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of GlaxoSmithKline.
Drugs Medical Pharma

Glenmark’s drug to treat nausea, psychosis gets FDA nod

India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of.

Read More
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.
Drugs Health Medical Pharma

FDA panel votes for full approval of Pfizer’s covid pill Paxlovid

The FDA’s advisory panel recommended full approval of Pfizer’s Covid antiviral treatment Paxlovid for high-risk adults.

Read More
The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations and share the results" with the global health agency.
Drugs Health Medical Pharma

New report opens a can of worms on COVID-19 origins, WHO steps in

The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations.

Read More
Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs in a programme aimed at valuing the efficacy of its Lyfe digital therapeutical platform.
Drugs Health Pharma

83.3% ACS patients achieve normality: Lupin Digital Health study

Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs.

Read More
Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million) for expansion in Montreal.
Drugs Medical Pharma

Jubilant HollisterStier gets $17.7 million Canadian funding

Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million).

Read More